Literature DB >> 7117311

Epsilon-aminocaproic acid myopathy. Report of a case and literature review.

J A Vanneste, G K van Wijngaarden.   

Abstract

A case of acute necrotic myopathy due to epsilon-aminocaproic acid (EACA) is described and compared with similar cases in the literature. This myopathy has only been noted after prolonged administration of the drug. The pathogenesis of this necrotic myopathy remains unclear, but our finds did not support a muscular vasculitis or an autoimmune reaction. Systematic preventive measures in patients with prolonged EACA therapy are proposed.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7117311     DOI： 10.1159/000115487

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


  4 in total

Review 1.  Antifibrinolytic Therapy and Perioperative Considerations.

Authors:  Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal:  Anesthesiology       Date:  2018-03       Impact factor: 7.892

Review 2.  Antifibrinolytic agents in subarachnoid haemorrhage.

Authors:  K W Lindsay
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

Review 3.  Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.

Authors:  Mark Chwajol; Robert M Starke; Grace H Kim; Stephan A Mayer; E Sander Connolly
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

4.  Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review.

Authors:  G Galassi; M Gibertoni; L Corradini; A Colombo
Journal:  Ital J Neurol Sci       Date:  1983-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.